HB 403: INSURANCE: Authorizes substitution of certain biosimilar biological products relative to…
2 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
HB 403
INSURANCE: Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols
Louisiana · Became law
Every link on this map
The same connections as a table, with the reason each one is here.
| Chad Brown | Sponsors | Chad Brown sponsored HB 403: INSURANCE: Authorizes substitution of certain biosimilar biological products relative to…. | None |
| INSURANCE: Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols | Source records | HB 403: INSURANCE: Authorizes substitution of certain biosimilar biological products relative to… has an explicit source reference to INSURANCE: Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…